Contributions of mucosal immune cells to methotrexate-induced mucositis

International Immunology

Volumn 18, Issue 6, 2006, Pages 941-949

  de Koning, Barbara A E ^a   van Dieren, Jolanda M ^b   Lindenbergh Kortleve, Dicky J ^a   van der Sluis, Maria ^a   Matsumoto, Tetsuya ^c   Yamaguchi, Keizo ^d   Einerhand, Alexandra W ^a   Samsom, Janneke N ^a   Pieters, Rob ^a   Nieuwenhuis, Edward E S ^a  

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c TOKYO MEDICAL UNIVERSITY   (Japan)

^d TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Innate and adaptive immune system; Intestinal damage; LPS; MTX

Indexed keywords

INTERLEUKIN 10; LIPOPOLYSACCHARIDE; METHOTREXATE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL FUNCTION; CELL ISOLATION; CELL STIMULATION; CELLULAR IMMUNITY; CONTROLLED STUDY; DISEASE COURSE; EX VIVO STUDY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HISTOPATHOLOGY; IMMUNE RESPONSE; IMMUNOASSAY; IMMUNOCOMPETENT CELL; IN VITRO STUDY; INNATE IMMUNITY; INTESTINE INJURY; LYMPHOCYTE; MOUSE; MUCOSA CELL; MUCOSA INFLAMMATION; NONHUMAN; PATHOGENESIS; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; WEIGHT REDUCTION; WILD TYPE;

ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; IMMUNITY, MUCOSAL; IMMUNITY, NATURAL; INTERLEUKIN-10; INTESTINAL MUCOSA; INTESTINES; LIPOPOLYSACCHARIDES; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; MACROPHAGES, PERITONEAL; METHOTREXATE; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; MUCOSITIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33745586794     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxl030     Document Type: Article

References (25)

1. Sonis, S. T., Elting, L. S., Keefe, D. et al. 2004. Perspectives on cancer therapy-induced mucosal injury: Pathogenesis, measurement, epidemiology, and consequences for patients. Cancer 100:1995.
2. Bellm, L. A., Epstein, J. B., Rose-Ped, A., Martin, P. and Fuchs, H. J. 2000. Patient reports of complications of bone marrow transplantation. Support. Care Cancer 8:33.
3. Elting, L. S., Cooksley, C., Chambers, M., Cantor, S. B., Manzullo, E. and Rubenstein, E. B. 2003. The burdens of cancer therapy. Clinical and economic outcomes of chemotherapy-induced mucositis. Cancer 98:1531.
4. Ruescher, T. J., Sodeifi, A., Scrivani, S. J., Kaban, L. B. and Sonis, S. T. 1998. The impact of mucositis on alpha-hemolytic streptococcal infection in patients undergoing autologous bone marrow transplantation for hematologic malignancies. Cancer 82:2275.
5. McGuire, D. B. 2002. Mucosal tissue injury in cancer therapy. More than muscositis and mouthwash. Cancer Pract. 10:179.
6. Meurman, J. H., Pyrhonen, S., Teerenhovi, L. and Lindqvist, C. 1997. Oral sources of septicaemia in patients with malignancies. Oral Oncol. 33:389.
7. Sonis, S. T. 1998. Mucositis as a biological process: A new hypothesis for the development of chemotherapy-induced stomatotoxicity. Oral Oncol. 34:39.
8. Keefe, D. M., Brealey, J., Goland, G. J. and Cummins, A. G. 2000. Chemotherapy for cancer causes apoptosis that precedes hypoplasia in crypts of the small intestine in humans. Gut 47:632.
9. Anilkumar, T. V., Sarraf, C. E., Hunt, T. and Alison, M. R. 1992. The nature of cytotoxic drug-induced cell death in murine intestinal crypts. Br. J. Cancer 65:552.
10. Strober, W., Fuss, I. J. and Blumberg, R. S. 2002. The immunology of mucosal models of inflammation. Annu. Rev. Immunol. 20:495.
11. Abreu-Martin, M. T., Vidrich, A., Lynch, D. H. and Targan, S. R. 1995. Divergent induction of apoptosis and IL-8 secretion in HT-29 cells in response to TNF-alpha and ligation of Fas antigen. J. Immunol. 155:4147.
12. Guy-Grand, D., DiSanto, J. P., Henchoz, P., Malassis-Seris, M. and Vassalli, P. 1998. Small bowel enteropathy: Role of intraepithelial lymphocytes and of cytokines (IL-12, IFN-gamma, TNF) in the induction of epithelial cell death and renewal. Eur. J. Immunol. 28:730.
13. Ricart, E., Panaccione, R., Loftus, E. V., Tremaine, W. J. and Sandborn, W. J. 2001. Infliximab for Crohn's disease in clinical practice at the Mayo Clinic: The first 100 patients. Am. J. Gastroenterol. 96:722.
14. Steidler, L., Hans, W., Schotte, L. et al. 2000. Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science 289:1352.
15. Braat, H., Rottiers, P., Huyghebaart, N. et al. 2005. Interleukin-10 producing Lactococcus lactis for the treatment of Crohn's disease. Gastroenterology 128(suppl 2):A-104 (abstract 685).
16. Sonis, S. T. 2004. The pathobiology of mucositis. Nat. Rev. Cancer 4:277.
17. Hall, P. D., Benko, H., Hogan, K. R. and Stuart, R. K. 1995. The influence of serum tumor necrosis factor-alpha and interleukin-6 concentrations on nonhematologic toxicity and hematologic recovery in patients with acute myelogenous leukemia. Exp. Hematol. 23:1256.
18. Sonis, S. T., Peterson, R. L., Edwards, L. J. et al. 2000. Defining mechanisms of action of interleukin-11 on the progression of radiation-induced oral mucositis in hamsters. Oral Oncol. 36:373.
19. Spielberger, R., Stiff, P., Bensinger, W. et al. 2004. Palifermin for oral mucositis after intensive therapy for hematologic cancers. N. Engl. J. Med. 351:2590.
20. Sultzer, B. M. 1969. Genetic factors in leucocyte responses to endotoxin: Further studies in mice. J. Immunol. 103:32.
21. Glode, L. M. and Rosenstreich, D. L. 1976. Genetic control of B cell activation by bacterial lipopolysaccharide is mediated by multiple distinct genes or alleles. J. Immunol. 117:2061.
22. Taminiau, J. A., Gall, D. G. and Hamilton, J. R. 1980. Response of the rat small-intestine epithelium to methotrexate. Gut 21:486.
23. Verburg, M., Renes, I. B., Meijer, H. P. et al. 2000. Selective sparing of goblet cells and paneth cells in the intestine of methotrexatetreated rats. Am. J. Physiol. Gastrointest. Liver Physiol. 279:G1037.
24. Coligan, C. E., Kruisbeek, A. M., Marqulies, D. H., Shevach, E. H. and Strober, W. 2002. Current Protocols in Immunology. Green Publishing and Wiley-Interscience, New York.
25. Nemzek, J. A., Ebong, S. J., Kim, J., Bolgos, G. L. and Remick, D. G. 2002. Keratinocyte growth factor pretreatment is associated with decreased macrophage inflammatory protein-2alpha concentrations and reduced neutrophil recruitment in acid aspiration lung injury. Shock 18:501.